Table 1.
Novel loci reaching genome-wide significance (P < 5 × 10-8) for the tails of anthropometric traits and clinical classes of obesity
Stage 1 | Stage 2* | Stage 1 + Stage 2 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||
SNP | Chr | Position | Nearby gene | Effect allele |
Other allele |
Effect allele freq |
No. cases |
No. controls |
OR | P | No. cases |
No. controls |
OR | P | No. cases |
No. controls |
OR | P |
Height tails
| ||||||||||||||||||
rs584438 | 17 | 35852698 | IGFBP4 | c | a | 0.617 | 7830 | 7850 | 1.18 | 1.11E-09 | 1814 | 1814 | 1.19 | 0.001 | 9644 | 9664 | 1.18 | 5.22E-12 |
rs6662509 | 1 | 9240191 | H6PD | t | c | 0.1463 | 5462 | 5461 | 1.23 | 2.21E-06 | 3615 | 3566 | 1.23 | 3.37E-05 | 9077 | 9027 | 1.23 | 3.19E-10 |
rs2362965 | 3 | 159592073 | RSRC1/SHOX2 | t | a | 0.50 | 7989 | 7993 | 1.14 | 1.45E-07 | 4819 | 4775 | 1.10 | 0.002 | 12808 | 12768 | 1.12 | 2.14E-09 |
rs1594829 | 8 | 26261994 | PPP2R2A | c | t | 0.7688 | 6693 | 6697 | 1.18 | 5.51E-07 | 4166 | 4115 | 1.11 | 0.01 | 10859 | 10812 | 1.15 | 3.88E-08 |
| ||||||||||||||||||
Obesity Class 2
| ||||||||||||||||||
rs7989336 | 13 | 95815549 | HS6ST3 | a | g | 0.4704 | 9825 | 62114 | 1.12 | 5.88E-09 | 1664 | 17113 | 1.04 | 0.25 | 11489 | 79226 | 1.10 | 1.06E-08 |
rs17381664 | 1 | 77820919 | ZZZ3 | c | t | 0.3923 | 9833 | 62114 | 1.11 | 7.61E-08 | 5351 | 33841 | 1.05 | 0.04 | 15184 | 95955 | 1.09 | 2.85E-08 |
| ||||||||||||||||||
Obesity Class 1
| ||||||||||||||||||
rs17024258 | 1 | 109948844 | GNAT2 | t | c | 0.0364 | 18662 | 38427 | 1.23 | 1.41E-06 | 8956 | 15471 | 1.28 | 1.12E-06 | 27618 | 53898 | 1.25 | 8.66E-12 |
rs4735692 | 8 | 76778218 | HNF4G | a | g | 0.5834 | 32675 | 65697 | 1.07 | 5.03E-08 | 22086 | 38352 | 1.04 | 0.005 | 54761 | 104049 | 1.06 | 2.48E-09 |
rs13041126 | 20 | 50526403 | MRPS33P4 | t | c | 0.7179 | 32020 | 64015 | 1.07 | 3.05E-07 | 22088 | 37595 | 1.04 | 0.007 | 54108 | 101610 | 1.06 | 2.16E-08 |
rs2531995 | 16 | 3953468 | ADCY9 | t | c | 0.6146 | 32433 | 65542 | 1.06 | 3.17E-06 | 6680 | 16602 | 1.07 | 0.004 | 39113 | 82144 | 1.07 | 4.04E-08 |
| ||||||||||||||||||
Overweight
| ||||||||||||||||||
rs4735692 | 8 | 76778218 | HNF4G | a | g | 0.5839 | 92703 | 65698 | 1.05 | 6.13E-09 | 65323 | 39290 | 1.03 | 0.003 | 158026 | 104988 | 1.04 | 3.51E-10 |
rs7503807 | 17 | 76205706 | RPTOR | a | c | 0.5654 | 92855 | 65723 | 1.04 | 4.20E-06 | 64535 | 38813 | 1.03 | 0.0009 | 157390 | 104536 | 1.04 | 1.98E-08 |
Stage 2 consists of studies with either GWAS and Metabochip data. Not all SNPs were present on Metabochip.